Data Sheet 1_Adaptation of thoracic and lumbar curvature and spinal muscle activity under changing gravity.pdf by Anita Meinke (14137836)

“…</p>Results<p>Spinal flattening was observed during micro-gravity exposure, with changes most pronounced in the upper lumbar and lower thoracic spine. Mean-normalized area between the back and backpack decreased significantly in micro-gravity compared to earth-gravity (p = 0.001), but not during hyper-gravity (p = 1.00). …”

Data Sheet 1_Use of the Temperament and Character Inventory to describe the effectiveness of Gestalt therapy.docx by Benjamin Calvet (11671588)

“…</p>Results<p>Statistically significant differences between the initial and final mean scores were observed for anxiety (t = 16.46; p < 0.0001), depression (t = 11.24; p < 0.0001), and harm avoidance (t = 8.82; p < 0.0001), and global psychological distress assessed by VAS (t = 18.7; p < 0.0001) (all showing decreased scores). …”

data-raw.xls by Jinlei Zhu (19952964)

“…Sap flow velocity and daily sap flow accumulation increased at 50% stumping but decreased at 75% and 100% stumping. …”

Effects of contralateral noise on CAEP (Lee et al., 2025) by Donguk Lee (21628297)

“…</p><p dir="ltr"><b>Results: </b>For the ipsilateral noise conditions, SNR had a significant effect on LLR latencies and interpeak amplitudes: Latencies decreased, and amplitudes increased as SNR improved. …”

SPIRIT Schedule of Enrollment. by Asma Salari (21432948)

“…</p><p>Materials and methods</p><p>Thirty women who were blind (mean age = 29.03 ± 2.20 years) were randomly assigned to an experimental (EX) group and a control (CO) group. …”

Measuring muscle strength [49]. by Asma Salari (21432948)

“…</p><p>Materials and methods</p><p>Thirty women who were blind (mean age = 29.03 ± 2.20 years) were randomly assigned to an experimental (EX) group and a control (CO) group. …”

Details of aquatic exercise protocol. by Asma Salari (21432948)

“…</p><p>Materials and methods</p><p>Thirty women who were blind (mean age = 29.03 ± 2.20 years) were randomly assigned to an experimental (EX) group and a control (CO) group. …”

Figure 5 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma by Marianna Carrabotta (8193039)

“…In the lung, the combined treatment led to a significant lower number of metastases compared with trabectedin (*, <i>P</i> < 0.05), or with NVP-BEZ235 (**, <i>P</i> < 0.01) as single agents. …”

Soil carbon, nitrogen, and phosphorus stoichiometry in subtropical forests of Zhejiang, China by Tonggui Wu (20215883)

“…Both SOC content and C:N ratio <a href="" target="_blank">exhibited non-linear trends with latitude</a>, initially decreasing and then increasing beyond a turning point at 29°N due to systematic grid-based soil sampling in Jinqu Basin with warmer conditions, which is different to global and China’s forests. …”

Data Sheet 1_Vagal nerve signals are modulated by spontaneous seizures in Genetic Absence Epilepsy Rats from Strasbourg.docx by Elise Collard (20913047)

“…</p>Results<p>Overall, VNA RMS increased during seizures, with a median rise of 60%. …”

Table 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Image 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Table 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Image 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Table 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Image 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Image 8_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tif by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Image 6_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Image 4_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tif by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”

Image 7_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…<p>The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. …”